Biochemistry and Molecular Laboratory LR00SP03, Children's Hospital of Tunis, Tunis, Tunisia.
Medical Analysis Laboratory (MauriLab), Nouakchott, Mauritania.
Mol Genet Genomic Med. 2022 Oct;10(10):e2048. doi: 10.1002/mgg3.2048. Epub 2022 Sep 15.
Hemoglobinopathies, inherited disorders of hemoglobin (Hb), are the most common hereditary monogenic diseases of the red cell in the world. Few studies have been conducted on hemoglobinopathies in Mauritania. Therefore, the aim of this work is to establish the molecular and epidemiological basis of hemoglobinopathies in a cohort of Mauritanian patients and to determine the haplotype of the β-globin gene cluster in sickle cell subjects.
The molecular screening of Hb disorders in 40 Mauritanian patients was done by a polymerase-restriction fragment length polymorphism (RFLP) for the sickle cell disease (SCD) mutation, a PCR/sequencing method for β-thalassemia mutations, and by the multiplex polymerase chain reaction method for the α-thalassemia. The exploration of eight polymorphic sites (SNPs) within the β-globin gene cluster was conducted by PCR/RFLP method, to identify the HbS haplotypes from the sickle cell subjects.
The epidemiological study of our patients showed a high incidence in the Senegal River area (52.5%) and a high ethnic prevalence for the Heratin (47.5%) and the Pular (35%). Molecular study allowed us to identify eight different mutations in our sample analyzed. They are respectively: HbS (HBB:c.20A>T) (68.75%), Cd44 -C (HBB:c.135delC) (8.75%), -29A>G (HBB:c.-79A>G) (4.8%), -α-3.7 (g.34164_37967del3804) (3.75%), IVS-II-849A>G (HBB:c.316-2A>G) (2.25%) and Cd24T>A (HBB:c.75T>A), Hb Siirt (HBB:c.83C>G) and HbC (HBB:c.19G>A) each with (1.25%). Six different haplotypes are being explored among the SCD subjects with the Senegal haplotype as the most prevalent (66.7%), followed by Benin (10%), Arab-Indians (6.7%), Bantu (3.3%), and two atypical haplotypes.
Our findings enrich the epidemiological data in our population and could contribute to the establishment of a strategy of prevention and management through screening, genetic counseling, and prenatal diagnosis of Hemoglobinopathies in the Mauritanian population.
血红蛋白病是血红蛋白(Hb)遗传性单基因疾病,是世界上最常见的遗传性红细胞疾病。毛里塔尼亚对血红蛋白病的研究较少。因此,本研究旨在建立毛里塔尼亚患者血红蛋白病的分子和流行病学基础,并确定镰状细胞患者β-珠蛋白基因簇的单倍型。
采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)对 40 例毛里塔尼亚患者的 Hb 紊乱进行分子筛查,检测镰状细胞病(SCD)突变;PCR/测序方法检测β-地中海贫血突变;多重聚合酶链反应方法检测α-地中海贫血。采用 PCR/RFLP 方法对β-珠蛋白基因簇内的 8 个多态性位点(SNP)进行研究,从镰状细胞患者中鉴定出 HbS 单倍型。
对患者的流行病学研究显示,塞内加尔河流域发病率较高(52.5%),赫塔汀(47.5%)和普卢拉(35%)的民族患病率较高。分子研究发现,我们分析的样本中存在八种不同的突变。它们分别是:HbS(HBB:c.20A>T)(68.75%)、Cd44-C(HBB:c.135delC)(8.75%)、-29A>G(HBB:c.-79A>G)(4.8%)、-α-3.7(g.34164_37967del3804)(3.75%)、IVS-II-849A>G(HBB:c.316-2A>G)(2.25%)和 Cd24T>A(HBB:c.75T>A)、Hb Siirt(HBB:c.83C>G)和 HbC(HBB:c.19G>A)各占 1.25%。在 SCD 患者中,共发现 6 种不同的单倍型,其中塞内加尔单倍型最为常见(66.7%),其次是贝宁(10%)、阿拉伯-印度(6.7%)、班图(3.3%)和两种非典型单倍型。
本研究结果丰富了我们人群的流行病学数据,并有助于通过筛查、遗传咨询和产前诊断,为毛里塔尼亚人群制定血红蛋白病的预防和管理策略。